Pharmacotherapy of Eating Disorders

被引：11

作者：

Jackson, Cherry Wyant ^{[1
]}

Cates, Marshall ^{[1
]}

Lorenz, Raymond ^{[2
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA

[2] Univ S Alabama, Mobile, AL 36688 USA

来源：

NUTRITION IN CLINICAL PRACTICE | 2010年 / 25卷 / 02期

关键词：

PLACEBO-CONTROLLED TRIAL; COGNITIVE-BEHAVIORAL THERAPY; BULIMIA-NERVOSA; ANOREXIA-NERVOSA; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENTS; SELF-HELP; FOLLOW-UP; BINGE; FLUOXETINE;

D O I：

10.1177/0884533610362239

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

Eating disorders are complex, chronic disorders that are difficult to treat. In addition, the 2 primary eating disorders, anorexia nervosa and bulimia nervosa, may have acute, life-threatening consequences. Medication trials for eating disorders have been hampered by high dropout rates, high placebo response, short trial duration, insufficient doses, and difficult outcome measures. Only 1 medication has been FDA approved for any eating disorder to date, and that is for fluoxetine in the treatment of bulimia. Clearly, new large-scale, independent studies using novel agents, and studying the use of medications for both short- and long-term outcomes, are needed. © 2010 American Society for Parenteral and Enteral Nutrition.

引用

页码：143 / 159

页数：17

共 79 条

[1]

AGRAS WS, 1994, J CLIN PSYCHIAT, V55, P179

[2] WEIGHT-LOSS, COGNITIVE-BEHAVIORAL, AND DESIPRAMINE TREATMENTS IN BINGE-EATING DISORDER - AN ADDITIVE DESIGN [J].

AGRAS, WS ;

TELCH, CF ;

ARNOW, B ;

ELDREDGE, K ;

WILFLEY, DE ;

RAEBURN, SD ;

HENDERSON, J ;

MARNELL, M .

BEHAVIOR THERAPY, 1994, 25 (02) :225-238

[3]

AGRAS WS, 1992, AM J PSYCHIAT, V149, P82

[4]

ALEXANDER W, 1997, DRUG TOPICS, V141, P6

[5]

[Anonymous], 1980, DSM 3

[6]

[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787

[7] A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder [J].

Appolinario, JC ;

Bacaltchuk, J ;

Sichieri, R ;

Claudino, AM ;

Godoy-Matos, A ;

Morgan, C ;

Zanella, MT ;

Coutinho, W .

ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (11) :1109-1116

[8] A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder [J].

Arnold, LM ;

McElroy, SL ;

Hudson, JI ;

Welge, JA ;

Bennett, AJ ;

Keck, PE .

JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) :1028-1033

[9] Does fluoxetine augment the inpatient treatment of anorexia nervosa? [J].

Attia, E ;

Haiman, C ;

Walsh, T ;

Flater, SR .

AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (04) :548-551

[10] Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa [J].

Barbarich, NC ;

McConaha, CW ;

Halmi, KA ;

Gendall, K ;

Sunday, SR ;

Gaskill, J ;

La Via, M ;

Frank, GK ;

Brooks, S ;

Plotnicov, KH ;

Kaye, WH .

INTERNATIONAL JOURNAL OF EATING DISORDERS, 2004, 35 (01) :10-15

← 1 2 3 4 5 6 7 8 →